止血剤と組織シーリング剤の市場規模、シェア、動向分析レポート：製品別、材料別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

止血剤と組織シーリング剤市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の止血剤と組織シーリング剤の市場規模は2030年までに144億8,000万米ドルに達すると予測されています。

同市場は2025～2030年にかけてCAGR 9.0％で成長すると予測されています。この成長は、侵襲性が低く回復に要する時間が短い低侵襲外科手術への嗜好が高まっていることに起因しています。さらに、医療技術の進歩や、手術を必要とする慢性疾患の有病率の上昇が、この成長に寄与しています。また、止血・組織シーリング製品の技術革新が進んでいることも市場の追い風となっています。これらの製品は、さまざまな医療専門セグメントのニーズを満たし、さまざまな医療環境で効果的かつ効率的な手術ソリューションを提供するために開発されています。

低侵襲技術の急速な成長と患者の早期回復に対する需要は、予測期間中の市場成長を促進すると予想されます。米国疾病予防管理センター（CDC）によると、現在、米国人口の約1億5,000万人が少なくとも1つの慢性疾患に罹患しており、そのために手術が必要となり、時には死亡することさえあります。このような手術件数の増加は、最終的に市場の成長を促進すると予想されています。

米国疾病予防管理センター（CDC）の推定によると、アメリカ全人口の48％以上が慢性疾患に罹患しており、これが市場成長の主要な促進要因の一つとなっています。また、止血・組織シーリング剤市場は、手術件数の増加、高齢者の増加、技術の進歩に支えられた製品需要の増加が見込まれています。市場参入企業の中には、市場ポジションを維持するために、製品の上市、M&A、製品承認に注力している企業もあります。例えば、2023年11月、Johnson & Johnsonの医療技術部門であるEthiconは、止血シーリングパッチであるEthiziaを発表し、欧州での発売承認を取得し、欧州での医療製品に重要な追加となりました。

止血剤と組織シーリング剤市場レポートハイライト

• 2024年、局所止血剤セグメントが最大の市場シェアを占めました。これは、従来の治療と併用されるケースが増加し、コスト効率、止血剤の迅速かつ容易な吸収性、最小限の組織反応性、非抗原性を提供するためです。
• 北米地域は、確立された医療インフラと、同地域における心血管障害、糖尿病、がんの有病率の増加により、2024年の市場シェアで最大を占めました。
• 市場参入企業は、製品リーチを拡大し、多様な地域での利用可能性を向上させるために、いくつかの戦略的イニシアチブを採用しています。
• 主要市場参入企業としては、Baxter、Johnson & Johnson、B. Braun、Smith & Nephew、Becton, Dickinson and Companyなどが挙げられます。
• 材料科学と生体工学の開発は、より優れた性能特性を持つ新しい改良型接着剤とシーリング剤の開発につながっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 止血剤と組織シーリング剤市場の変数、動向、範囲

• 市場系統の展望
  • 親市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 止血剤と組織シーリング剤市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 止血剤と組織シーリング剤市場：製品別、推定・動向分析

• セグメントダッシュボード
• 止血剤と組織シーリング剤市場：製品変動分析と市場シェア、2023年と2030年
• 局所止血剤
• 合成止血剤

第5章 止血剤と組織シーリング剤市場：材料別、推定・動向分析

• セグメントダッシュボード
• 止血剤と組織シーリング剤市場：材料変動分析と市場シェア、2023年と2030年
• ゼラチンベースの局所止血剤
• コラーゲンベースの局所止血剤
• ORCベースの局所止血剤
• 多糖類ベースの局所止血剤

第6章 止血剤と組織シーリング剤市場：用途別、推定・動向分析

• セグメントダッシュボード
• 止血剤と組織シーリング剤市場：用途変動分析と市場シェア、2023年と2030年
• 一般外科
• 脳神経外科
• 血管外科
• 心臓血管外科
• その他

第7章 止血剤と組織シーリング剤市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 止血剤と組織シーリング剤市場：最終用途変動分析と市場シェア、2024年と2030年
• 病院
• 外来手術センター
• その他

第8章 止血剤と組織シーリング剤市場：地域別、推定・動向分析

• 地域展望
• 止血剤と組織シーリング剤市場：地域変動分析と市場シェア、2024年と2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Johnson & Johnson
  • CryoLife Inc
  • Advance Medical Solution（AMS）Group Plc
  • Cohera Medical Inc
  • Integra Life Sciences Corporation
  • Pfizer
  • BD
  • Cohesion Technologies Inc
  • HyperBranch Medical Technology
  • Biomet Inc
  • Medtronic
  • B Braun Medical Inc
  • Smith &Nephew

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global hemostats market, by product, 2018 - 2030 (USD Million)
• Table 4 Global hemostats market, by material, 2018 - 2030 (USD Million)
• Table 5 Global hemostats market, by application, 2018 - 2030 (USD Million)
• Table 6 Global hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 7 North America hemostasis and tissue sealing agents market, by region, 2018 - 2030 (USD Million)
• Table 8 North America market, by product, 2018 - 2030 (USD Million)
• Table 9 North America hemostats market, by material, 2018 - 2030 (USD Million)
• Table 10 North America hemostats market, by application, 2018 - 2030 (USD Million)
• Table 11 North America hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 12 U.S. hemostats market, by product, 2018 - 2030 (USD Million)
• Table 13 U.S. hemostats market, by material, 2018 - 2030 (USD Million)
• Table 14 U.S. hemostats market, by application, 2018 - 2030 (USD Million)
• Table 15 U.S. hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 16 Canada hemostats market, by product, 2018 - 2030 (USD Million)
• Table 17 Canada hemostats market, by material, 2018 - 2030 (USD Million)
• Table 18 Canada hemostats market, by application, 2018 - 2030 (USD Million)
• Table 19 Canada hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Europe hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
• Table 21 Europe hemostats market, by product, 2018 - 2030 (USD Million)
• Table 22 Europe hemostats market, by material, 2018 - 2030 (USD Million)
• Table 23 Europe hemostats market, by application, 2018 - 2030 (USD Million)
• Table 24 Europe hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 25 UK hemostats market, by product, 2018 - 2030 (USD Million)
• Table 26 UK hemostats market, by material, 2018 - 2030 (USD Million)
• Table 27 UK hemostats market, by application, 2018 - 2030 (USD Million)
• Table 28 UK hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 29 Germany hemostats market, by product, 2018 - 2030 (USD Million)
• Table 30 Germany hemostats market, by material, 2018 - 2030 (USD Million)
• Table 31 Germany hemostats market, by application, 2018 - 2030 (USD Million)
• Table 32 Germany hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 33 France hemostats market, by product, 2018 - 2030 (USD Million)
• Table 34 France hemostats market, by material, 2018 - 2030 (USD Million)
• Table 35 France hemostats market, by application, 2018 - 2030 (USD Million)
• Table 36 France hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 37 Italy hemostats market, by product, 2018 - 2030 (USD Million)
• Table 38 Italy hemostats market, by material, 2018 - 2030 (USD Million)
• Table 39 Italy hemostats market, by application, 2018 - 2030 (USD Million)
• Table 40 Italy hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 41 Spain hemostats market, by product, 2018 - 2030 (USD Million)
• Table 42 Spain hemostats market, by material, 2018 - 2030 (USD Million)
• Table 43 Spain hemostats market, by application, 2018 - 2030 (USD Million)
• Table 44 Spain hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 45 Norway hemostats market, by product, 2018 - 2030 (USD Million)
• Table 46 Norway hemostats market, by material, 2018 - 2030 (USD Million)
• Table 47 Norway hemostats market, by application, 2018 - 2030 (USD Million)
• Table 48 Norway hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Sweden hemostats market, by product, 2018 - 2030 (USD Million)
• Table 50 Sweden hemostats market, by material, 2018 - 2030 (USD Million)
• Table 51 Sweden hemostats market, by application, 2018 - 2030 (USD Million)
• Table 52 Sweden hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 53 Denmark hemostats market, by product, 2018 - 2030 (USD Million)
• Table 54 Denmark hemostats market, by material, 2018 - 2030 (USD Million)
• Table 55 Denmark hemostats market, by application, 2018 - 2030 (USD Million)
• Table 56 Denmark hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific hemostats market, by product, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific hemostats market, by material, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific hemostats market, by application, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 62 Japan hemostats market, by product, 2018 - 2030 (USD Million)
• Table 63 Japan hemostats market, by material, 2018 - 2030 (USD Million)
• Table 64 Japan hemostats market, by application, 2018 - 2030 (USD Million)
• Table 65 Japan hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 66 China hemostats market, by product, 2018 - 2030 (USD Million)
• Table 67 China hemostats market, by material, 2018 - 2030 (USD Million)
• Table 68 China hemostats market, by application, 2018 - 2030 (USD Million)
• Table 69 China hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 70 India hemostats market, by product, 2018 - 2030 (USD Million)
• Table 71 India hemostats market, by material, 2018 - 2030 (USD Million)
• Table 72 India hemostats market, by application, 2018 - 2030 (USD Million)
• Table 73 India hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 74 Australia hemostats market, by product, 2018 - 2030 (USD Million)
• Table 75 Australia hemostats market, by material, 2018 - 2030 (USD Million)
• Table 76 Australia hemostats market, by application, 2018 - 2030 (USD Million)
• Table 77 Australia hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 78 South Korea hemostats market, by product, 2018 - 2030 (USD Million)
• Table 79 South Korea hemostats market, by material, 2018 - 2030 (USD Million)
• Table 80 South Korea hemostats market, by application, 2018 - 2030 (USD Million)
• Table 81 South Korea hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 82 Thailand hemostats market, by product, 2018 - 2030 (USD Million)
• Table 83 Thailand hemostats market, by material, 2018 - 2030 (USD Million)
• Table 84 Thailand hemostats market, by application, 2018 - 2030 (USD Million)
• Table 85 Thailand hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 86 Latin America hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
• Table 87 Latin America hemostats market, by product, 2018 - 2030 (USD Million)
• Table 88 Latin America hemostats market, by material, 2018 - 2030 (USD Million)
• Table 89 Latin America hemostats market, by application, 2018 - 2030 (USD Million)
• Table 90 Latin America hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 91 Brazil hemostats market, by product, 2018 - 2030 (USD Million)
• Table 92 Brazil hemostats market, by material, 2018 - 2030 (USD Million)
• Table 93 Brazil hemostats market, by application, 2018 - 2030 (USD Million)
• Table 94 Brazil hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 95 Mexico hemostats market, by product, 2018 - 2030 (USD Million)
• Table 96 Mexico hemostats market, by material, 2018 - 2030 (USD Million)
• Table 97 Mexico hemostats market, by application, 2018 - 2030 (USD Million)
• Table 98 Mexico hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 99 Argentina hemostats market, by product, 2018 - 2030 (USD Million)
• Table 100 Argentina hemostats market, by material, 2018 - 2030 (USD Million)
• Table 101 Argentina hemostats market, by application, 2018 - 2030 (USD Million)
• Table 102 Argentina hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 103 Middle East & Africa hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa hemostats market, by product, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa hemostats market, by material, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa hemostats market, by application, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 108 South Africa hemostats market, by product, 2018 - 2030 (USD Million)
• Table 109 South Africa hemostats market, by material, 2018 - 2030 (USD Million)
• Table 110 South Africa hemostats market, by application, 2018 - 2030 (USD Million)
• Table 111 South Africa hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia hemostats market, by product, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia hemostats market, by material, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia hemostats market, by application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 116 UAE hemostats market, by product, 2018 - 2030 (USD Million)
• Table 117 UAE hemostats market, by material, 2018 - 2030 (USD Million)
• Table 118 UAE hemostats market, by application, 2018 - 2030 (USD Million)
• Table 119 UAE hemostats market, by end-use, 2018 - 2030 (USD Million)
• Table 120 Kuwait hemostats market, by product, 2018 - 2030 (USD Million)
• Table 121 Kuwait hemostats market, by material, 2018 - 2030 (USD Million)
• Table 122 Kuwait hemostats market, by application, 2018 - 2030 (USD Million)
• Table 123 Kuwait hemostats market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Hemostats market segmentation
• Fig. 7 Market driver analysis (Current & future impact)
• Fig. 8 Market restraint analysis (Current & future impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Hemostasis and tissue sealing agents market, product outlook key takeaways (USD Million)
• Fig. 12 Hemostasis and tissue sealing agents market: product movement analysis 2024 & 2030 (USD Million)
• Fig. 13 Topical hemostat market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Adhesive & tissue sealant market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Hemostasis and tissue sealing agents market, material outlook key takeaways (USD Million)
• Fig. 16 Hemostasis and tissue sealing agents market: material movement analysis 2024 & 2030 (USD Million)
• Fig. 17 Gelatin-based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Collagen based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 ORC- based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Polysaccharide-based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Hemostasis and tissue sealing agents market, application outlook key takeaways (USD Million)
• Fig. 22 Hemostasis and tissue sealing agents market: application movement analysis 2024 & 2030 (USD Million)
• Fig. 23 General surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Neurosurgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Vascular surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Cardiovascular surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Hemostasis and tissue sealing agents market, end-use outlook key takeaways (USD Million)
• Fig. 29 Hemostasis and tissue sealing agents market: end-use movement analysis 2024 & 2030 (USD Million)
• Fig. 30 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Hemostasis and tissue sealing agents market : Regional key takeaways (USD Million)
• Fig. 34 Hemostasis and tissue sealing agents market: Regional outlook, 2024 & 2030 (USD Million)
• Fig. 35 North America hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 U.S. hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Canada hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Europe hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 UK hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Germany hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 France hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Spain hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Italy hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Sweden hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Norway hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Denmark hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Asia Pacific hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 China hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Japan hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 India hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 South Korea hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Australia hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Thailand hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Latin America hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Brazil hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Mexico hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Argentina hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Middle East and Africa hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 South Africa hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Saudi Arabia hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 UAE hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Kuwait hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 List of key emerging company's/technology disruptors/innovators

Hemostasis And Tissue Sealing Agents Market Growth & Trends:

The global hemostasis and tissue sealing agents market size is anticipated to reach USD 14.48 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.0% from 2025 to 2030. This growth can be attributed to the increasing preference towards minimally invasive surgical procedures, which are less invasive and require less recovery time. Additionally, advancements in healthcare technology and the rising prevalence of chronic diseases that require surgery are contributing to this growth. The market is also benefiting from ongoing innovation in hemostatic and tissue sealing products, which are being developed to meet the needs of a wide range of medical specialties and to provide effective and efficient surgical solutions in various healthcare settings.

The rapid growth of minimally invasive technology and the demand for faster recovery by patients are expected to promote market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of the American population are currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times. Such a rise in the number of surgeries is eventually anticipated to foster market growth.

The Centers for Disease Control and Prevention (CDC) estimates that over 48% of the entire American population is expected to suffer from chronic conditions, which is one of the key drivers of this growth. The hemostasis & tissue sealing agents market is also expected to witness an increase in product demand supported by rising surgery volumes, growth in the geriatric population, and technological advancements. Several market participants are focusing on product launches, merger & acquisitions & product approval to sustain their market position. For instance, In November 2023, Johnson & Johnson's MedTech division, Ethicon, introduced Ethizia, a hemostatic sealing patch, obtaining European approval for its launch, marking a significant addition to their medical offerings in Europe.

Hemostasis And Tissue Sealing Agents Market Report Highlights:

• In 2024, the topical hemostat segment accounted for the largest market share due to its rising use with conventional treatment to provide cost-efficiency, quick & easy absorbability of the hemostatic agent, minimal tissue reactivity, and non-antigenicity.
• The North American region held the largest share of the market in 2024 due to well-established healthcare infrastructure, and the growing prevalence of cardiovascular disorders, diabetes, and cancer within the region.
• Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas.
• Some of the major market players are Baxter, Johnson & Johnson, B. Braun, Smith & Nephew, Becton, Dickinson, and Company
• Advancements in material science and bioengineering have led to the development of new and improved adhesives and sealants with better performance characteristics.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Hemostasis & Tissue Sealing Agents Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Rising preference towards minimally invasive surgical procedures
    • 3.2.1.3. Growing geriatric population
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Product recall & failure
• 3.3. Hemostasis & Tissue Sealing Agents Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Hemostasis & Tissue Sealing Agents Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Hemostasis & Tissue Sealing Agents Market: Product Movement Analysis & Market Share, 2023 & 2030
• 4.3. Topical Hemostats
  • 4.3.1. Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.1. Active
      • 4.3.1.1.1. Active market estimates and forecast 2018 to 2030 (USD Million)
    • 4.3.1.2. Mechanical
      • 4.3.1.2.1. Mechanical market estimates and forecast 2018 to 2030 (USD Million)
    • 4.3.1.3. Flowable
      • 4.3.1.3.1. Flowable market estimates and forecast 2018 to 2030 (USD Million)
    • 4.3.1.4. Adhesive & Tissue Sealant
      • 4.3.1.4.1. Adhesive & Tissue Sealant market estimates and forecast 2018 to 2030 (USD Million)
• 4.4. Synthetic Hemostats
  • 4.4.1. Synthetic Hemostasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.1. Natural
      • 4.4.1.1.1. Natural market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.1.2. Adhesion Barrier
      • 4.4.1.2.1. Adhesion Barrier market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Hemostasis & Tissue Sealing Agents Market: Material Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Hemostasis & Tissue Sealing Agents Market: Material Movement Analysis & Market Share, 2023 & 2030
• 5.3. Gelatin-based Topical Hemostats
  • 5.3.1. Gelatin-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Collagen-based Topical Hemostats
  • 5.4.1. Gelatin-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. ORC-based Topical Hemostats
  • 5.5.1. ORC-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Polysaccharide-based Topical Hemostats
  • 5.6.1. Polysaccharide-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hemostasis & Tissue Sealing Agents Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Hemostasis & Tissue Sealing Agents Market: Application Movement Analysis & Market Share, 2023 & 2030
• 6.3. General Surgery
  • 6.3.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Neurosurgery
  • 6.4.1. Neurosurgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Vascular Surgery
  • 6.5.1. Vascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Cardiovascular Surgery
  • 6.6.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Hemostasis & Tissue Sealing Agents Market: End-use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Hemostasis & Tissue Sealing Agents Market: End-use Movement Analysis & Market Share, 2024 & 2030
• 7.3. Hospitals
  • 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Ambulatory Surgical Centers
  • 7.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Others
  • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Hemostasis & Tissue Sealing Agents Market: Regional Estimates & Trend Analysis

• 8.1. Regional Outlook
• 8.2. Hemostasis & Tissue Sealing Agents Market: Regional Movement Analysis & Market Share, 2024 & 2030
• 8.3. North America
  • 8.3.1. North Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. UK Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. Germany Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. France Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Italy Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Spain Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Denmark Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Sweden Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Reimbursement scenario
    • 8.4.9.5. Norway Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. Japan Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. China Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. India Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. South Korea Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Australia Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. Thailand Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Brazil Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Mexico
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. Mexico Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. Argentina
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement scenario
    • 8.6.4.5. Argentina Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Middle East & Africa
  • 8.7.1. Middle East & Africa Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. South Africa Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Saudi Arabia Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. UAE Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Reimbursement scenario
    • 8.7.5.5. Kuwait Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. Johnson & Johnson
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. CryoLife Inc
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Product benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. Advance Medical Solution (AMS) Group Plc
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. Cohera Medical Inc
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Integra Life Sciences Corporation
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Pfizer
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. BD
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Cohesion Technologies Inc
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. HyperBranch Medical Technology
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. Biomet Inc
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. Medtronic
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Product benchmarking
    • 9.2.11.4. Strategic initiatives
  • 9.2.12. B Braun Medical Inc
    • 9.2.12.1. Company overview
    • 9.2.12.2. Financial performance
    • 9.2.12.3. Product benchmarking
    • 9.2.12.4. Strategic initiatives
  • 9.2.13. Smith & Nephew
    • 9.2.13.1. Company overview
    • 9.2.13.2. Financial performance
    • 9.2.13.3. Product benchmarking
    • 9.2.13.4. Strategic initiatives